Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC

Introduction: The impact of an immune checkpoint inhibitor (ICI)–based systemic treatment strategy with or without local radical treatment (LRT) on outcomes for patients with NSCLC and synchronous oligometastatic disease (sOMD) is unknown. Methods: Multicenter retrospective study including adequatel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mandy Jongbloed, MD, Valentina Bartolomeo, MD, Martina Bortolot, MD, Shahan Darwesh, MD, Jarno W.J. Huijs, MD, Safiye Dursun, MD, Juliette Degens, MD, PhD, Ben E.E.M. van den Borne, MD, PhD, Maggy Youssef-El Soud, MD, PhD, Marcel Westenend, MD, PhD, Cordula Pitz, MD, PhD, Dirk K.M. De Ruysscher, MD, PhD, Lizza E.L. Hendriks, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	JTO Clinical and Research Reports
Subjects:	NSCLC Synchronous oligometastatic disease Immune checkpoint inhibitors Progression free survival Overall survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364325000062
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC

Similar Items